secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ainos, Inc. (AIMD)
CIK:        0001014763
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001641172-25-009580
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ainos Q1 revenue up 412% to $106K; gross profit swings to positive; partnerships in robotics and semiconductors
--------------------------------------------------------------------------------

- Revenue up 412% YoY to $106,207; gross profit of $87,974 vs prior-year gross loss of $6,025.
- Cost of revenue down 32% YoY to $18,233, driving gross margin improvement.
- AI Nose deployed in semiconductor manufacturing via ASE partnership; olfactory module installed on ugo robots.
- VELDONA secured TFDA approval for HIV oral warts trial and IRB clearance for Sjögren's syndrome trial.
- No net income or EPS disclosed; share-based compensation increased SG&A expenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1014763/000164117225009580/0001641172-25-009580-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1014763/000164117225009580/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-009580

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer